DPW
AGIO icon

DiNuzzo Private Wealth’s Agios Pharmaceuticals AGIO Stock Holding History

DiNuzzo Private Wealth’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$38 – 1369
2025
Q3 		$38 Hold
1
– – ﹤0.01% 1352
2025
Q2 		$34 Sell
1
-1
-50% -$30 ﹤0.01% 1346
2025
Q1 		$59 Sell
2
-4
-67% -$133 ﹤0.01% 1325
2024
Q4 		$198 Buy
6
+4
+200% +$188 ﹤0.01% 1267
2024
Q3 		$89 Buy
+2
New +$91 ﹤0.01% 1376
2024
Q1 		– Sell
-1
Closed -$23 – 1367
2023
Q4 		$23 Buy
+1
New +$22 ﹤0.01% 1378

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

DiNuzzo Private Wealth's AGIO Position: Q4 2025 in Review

DiNuzzo Private Wealth sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 1 share — an estimated $38 sold.

DiNuzzo Private Wealth first reported a position in AGIO in Q4 2023 and held it in 6 quarters. The position peaked at $198 in Q4 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • DiNuzzo Private Wealth reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • DiNuzzo Private Wealth sold 1 Agios Pharmaceuticals share in Q4 2025, an estimated $38.
  • DiNuzzo Private Wealth first reported a position in Agios Pharmaceuticals in Q4 2023 and held it in 6 quarters.
  • DiNuzzo Private Wealth's Agios Pharmaceuticals position peaked at $198 in Q4 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on DiNuzzo Private Wealth's 13F filing for Q4 2025, filed 16 Jan 2026.